我没有偏好，我只是说这个钙调神经磷酸酶抑制剂是非常成熟的药了，用了很长

I have no preference, I just said that this calcineurin inhibitor is a very mature drug, and it has been used for a long time, including cyclosporine and tacrolimus are very mature, since there are mature drugs It should be head-to-head with mature drugs, not just for effectiveness. If this drug has never been used before, and no equivalent product has come out, a drug effectiveness test should be done, and it is effective. Second, if the drug is mature, you just have a new and updated product in this structure, and you should do a head-to-head test.

I have no preference, I just say that this calcium-adjusted neurophosphatase inhibitor is very mature medicine, used for a long time, including cyclosporine and his kemos are very mature, since there are mature drugs should be head-to-head with mature drugs, can not only do effectiveness, if this drug has never been, there is no equivalent product out, should do drug effectiveness testing, it is effective. Second, if the drug is mature, you just have a new replacement product in this structure, and you should do a head-to-head experiment.

I have no preference. I just said that this calcineurin inhibitor is a very mature drug, which has been used for a long time, including cyclosporin and tacrolimus. Since there are mature drugs, we should make head-on confrontation with mature drugs, not just for effectiveness. If this drug has never been used, and no equivalent product has been produced, we should conduct drug efficacy test It is effective. Second, if the drug is mature, and you just come up with a new and updated product on this structure, you should do head-to-head trials.